Overview of a Phase Ib study of venetoclax and obinutuzumab in CLL
Is an early diagnosis of CLL beneficial in its treatment?
The iwCLL 2017 meeting
Importance of prognostic factors in the treatment of CLL and how to assess them
Can ibrutinib be used as a first-line treatment in CLL?